Does Ozempic cause heart palpitations?

Ozempic can cause palpitations in a minority of patients, mostly indirectly through dehydration, electrolyte loss, anxiety, or blood sugar swings. The direct effect on heart rate is a modest 2 to 4 bpm increase.

Does Ozempic raise heart rate?

Yes. The FDA label documents an average resting heart rate increase of 2 to 4 beats per minute in clinical trials. The effect is small, appears within weeks, and is stable over time.

Why does semaglutide increase heart rate?

GLP-1 receptors exist in cardiac tissue and in brainstem autonomic centers. Activation produces a small sympathetic chronotropic effect that the vagal counter-response does not fully cancel.

Does Wegovy cause heart palpitations?

At the same rate as Ozempic, roughly. Wegovy is the same molecule at a slightly higher maximum dose. The cardiac side-effect profile is essentially identical.

Can Ozempic cause a heart attack?

No. Clinical trials including SUSTAIN-6 and SELECT showed semaglutide reduces the risk of heart attack in at-risk patients. New chest pain still needs urgent evaluation, but the medication itself lowers cardiac event risk.

Is Ozempic good for your heart?

For patients with type 2 diabetes and cardiovascular disease, or obesity with cardiovascular disease, yes. SELECT showed a 20 percent reduction in major adverse cardiovascular events with semaglutide 2.4 mg weekly.

Can Ozempic cause blood clots?

No clinical trial signal supports an increased blood clot risk on semaglutide. SELECT showed fewer strokes in the semaglutide arm, not more.

Should I stop Ozempic if I get palpitations?

Not on your own. Most palpitations resolve with hydration, electrolyte replacement, and time. Call your prescriber. Stop and seek urgent care if palpitations come with chest pain, fainting, or shortness of breath.

How long do Ozempic heart palpitations last?

When they occur, most cases are brief, lasting seconds to minutes, and cluster in the first 8 to 12 weeks of treatment or after a dose increase. Persistent or worsening palpitations need a doctor visit.

Can I take Ozempic with a beta-blocker?

Yes. There is no direct interaction. The main caution is that beta-blockers mask hypoglycemia symptoms, which matters more if you also take insulin or a sulfonylurea.

What is the SELECT trial?

A 2023 NEJM trial of 17,604 adults with obesity and cardiovascular disease but no diabetes. Semaglutide 2.4 mg weekly reduced the composite of cardiovascular death, nonfatal heart attack, or nonfatal stroke by 20 percent versus placebo.

Ozempic Heart Palpitations: Causes and When to Worry

Summary: An average heart rate increase of 2 to 4 beats per minute is on the FDA Ozempic label. Palpitations are reported but not common, and most cases trace back to dehydration, electrolyte loss, or blood sugar swings rather than a direct cardiac problem.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: Ozempic raises resting heart rate by an average of 2 to 4 beats per minute, which is documented directly on the FDA label ^[1]. True palpitations, the sensation of your heart fluttering, racing, or skipping, are reported but not listed among the common side effects. When palpitations do happen on Ozempic, they are usually indirect, driven by dehydration from vomiting or diarrhea, electrolyte shifts, anxiety in the first weeks of titration, or blood sugar swings in type 2 diabetes. The cardiovascular story for semaglutide as a whole is strongly positive: the SELECT trial in NEJM showed a 20 percent reduction in major adverse cardiovascular events ^[2].

Here is how to tell when a fast heartbeat on Ozempic is the medication, when it is a downstream effect of something else, and when it is the thing that sends you to urgent care.

What the FDA label actually says about heart rate

The Ozempic prescribing information includes a section on heart rate. In the SUSTAIN clinical trial program, semaglutide produced a mean increase in resting heart rate of 2 to 4 beats per minute compared to placebo ^[1]^[3]. The Wegovy label, which uses the same molecule at higher doses, reports a similar magnitude, around 1 to 4 bpm in STEP trials ^[4]. This is a real, reproducible pharmacologic effect, not noise.

Palpitations as a self-reported symptom appear in post-marketing reports and in some clinical trial adverse event tables at low single-digit rates. They are not listed as "common" (≥5 percent) in the Ozempic label. Compare that to nausea, which lands around 15 to 20 percent depending on the dose. Palpitations are in the same tier as headache and dizziness: real, worth tracking, but not the dominant side effect.

Why GLP-1 medications nudge heart rate up

The mechanism is not fully nailed down but the leading explanations are direct sympathetic nervous system effects on the sinoatrial node, plus a vagal counter-response that does not fully offset the chronotropic push. GLP-1 receptors exist in cardiac tissue and in the brainstem regions that regulate autonomic tone. Semaglutide, liraglutide, and other GLP-1 receptor agonists all show this small heart rate uptick, so it is a class effect, not an Ozempic-specific quirk.

The effect appears within the first few weeks of treatment and persists for the duration of dosing. It does not progressively worsen over time. Stopping the drug returns heart rate to baseline.

Indirect causes of palpitations on Ozempic

Most palpitation reports trace back not to the heart-rate effect itself but to downstream consequences of the medication.

Dehydration from GI side effects

Nausea, vomiting, and diarrhea are the headline Ozempic side effects, and they peak during titration. Lose enough fluid volume and your heart compensates by beating faster and harder. That hard beat is what people feel as a palpitation. Standing up after a few days of poor fluid intake can produce a brief tachycardia that feels alarming but resolves with water and salt.

Electrolyte imbalance

Vomiting strips out potassium and chloride. Diarrhea takes potassium and magnesium. Low potassium and low magnesium are two of the most common triggers for true premature ventricular contractions, the most common "skipped beat" sensation in healthy adults. If you have been losing GI fluid for several days and the palpitations started after, electrolytes are the first thing to check.

Anxiety and the first-dose effect

Starting a new injectable medication that is in the news constantly produces measurable anticipatory anxiety in a real fraction of patients. Anxiety raises heart rate. The first week of Ozempic is the worst for this. If your palpitations are tied to thinking about the medication, happen in clusters around the injection day, and have no other physical cause, anxiety is on the differential.

Blood sugar swings in type 2 diabetes

In people with diabetes, hypoglycemia from Ozempic combined with insulin or a sulfonylurea is a known palpitation trigger. Low blood sugar drives an adrenergic surge: sweating, tremor, racing heart. If you are on Ozempic plus another glucose-lowering agent and the palpitations come with sweating or shakiness, check your glucose before you check your pulse.

How to tell if palpitations are Ozempic related

Three clues point toward the medication.

Clue	Suggests Ozempic link	Suggests other cause
Timing	Started within 1 to 8 weeks of starting or dose increase	Predates Ozempic or starts months after a stable dose
Rate	Mild, sustained increase of 2 to 10 bpm above your baseline	Sudden onset of 130+ bpm with no trigger
Accompanying symptoms	GI upset, mild lightheadedness on standing	Chest pain, fainting, severe shortness of breath

Track your resting heart rate for two weeks before Ozempic and two weeks after each dose increase. A smartwatch is fine. If your resting rate climbed 3 to 5 bpm and your palpitations are brief and infrequent, the math is consistent with the label finding.

If your resting rate is jumping by 20 or more bpm, if you are getting episodes of clearly irregular rhythm, or if exertion brings on chest pressure, the workup belongs with your doctor and ideally an ECG.

When to call your doctor

Some symptoms are not "wait and see" symptoms. Call the same day, or go to urgent care or the ER, for any of these.

Chest pain or pressure, especially with exertion or with the palpitations
Palpitations that feel irregular rather than fast and regular
Fainting or near-fainting
Shortness of breath at rest
A sustained heart rate above 120 bpm with no clear trigger
Palpitations accompanied by sweating and confusion, which can signal severe hypoglycemia

For milder palpitations that come and go without other symptoms, raise it at your next appointment but do not wait six months. An ECG and a basic metabolic panel cover most of the diagnostic ground in under an hour.

What to do at home

Three interventions handle most Ozempic-related palpitations.

Hydrate aggressively. Aim for 80 to 100 ounces of fluid per day during titration weeks and any time GI symptoms flare. Plain water is fine. If you have been vomiting or have had diarrhea, switch to an oral rehydration solution or a low-sugar electrolyte drink for at least 24 hours.
Replace electrolytes. Salt your food. Eat potassium-rich foods like bananas, avocado, potatoes, and leafy greens. If you are restricting calories aggressively along with Ozempic, you are doubly at risk for low electrolytes; a multivitamin with magnesium covers the common gap.
Monitor your pulse. Take your resting heart rate first thing in the morning, before coffee. Log it for two weeks. If it climbs by more than 10 bpm above your baseline and stays there, share that data with your prescriber.

Caffeine is the easy lever. If you are on Ozempic and getting palpitations, cut caffeine for two weeks and see if they resolve. Caffeine, dehydration, and a small drug-induced chronotropic effect stack additively. Remove one variable and the symptom often disappears.

Beta-blockers and Ozempic

Some patients on beta-blockers (metoprolol, atenolol, propranolol, carvedilol) wonder whether they should adjust their dose when starting Ozempic. The short answer is no, not preemptively. Beta-blockers blunt the heart rate response to many stimuli including the modest Ozempic chronotropic effect. If anything, the heart rate increase from semaglutide is harder to notice on a beta-blocker.

The more important interaction is functional: beta-blockers mask the early warning signs of hypoglycemia. The classic sweating-tremor-palpitation triad is partly suppressed. In a patient on Ozempic plus insulin or a sulfonylurea plus a beta-blocker, severe hypoglycemia can arrive without the usual prodrome. That is a conversation to have with your prescriber, not a reason to stop any of the three medications on your own.

The SELECT trial and the bigger cardiovascular picture

The 2023 SELECT trial in the New England Journal of Medicine enrolled 17,604 adults with obesity (BMI 27 or higher) and pre-existing cardiovascular disease but without diabetes. Half got semaglutide 2.4 mg weekly (the Wegovy dose), half got placebo. Median follow-up was about 40 months ^[2].

Results: the primary composite endpoint of cardiovascular death, nonfatal heart attack, or nonfatal stroke occurred in 6.5 percent of the semaglutide group versus 8.0 percent of the placebo group. That is a 20 percent relative risk reduction, statistically significant, and consistent across subgroups. SUSTAIN-6, the earlier trial in patients with type 2 diabetes, showed a similar direction of benefit ^[3].

The mean heart rate increase observed in SELECT was about 3 bpm. The composite cardiovascular benefit outweighed that small chronotropic effect by a substantial margin. Said plainly: the average patient at cardiovascular risk does better on semaglutide than off it, even accounting for the heart rate uptick.

That does not mean every individual benefits. It does mean that the population-level data point against the framing that semaglutide is "bad for the heart." The clinical guidance from the American Diabetes Association and the American College of Cardiology now positions GLP-1 receptor agonists, including semaglutide, as preferred agents in patients with type 2 diabetes and established cardiovascular disease.

What about blood clots, tachycardia, and heart muscle effects

The blood clot question circulates online and the answer is straightforward: there is no clinical trial signal that Ozempic increases the risk of venous thromboembolism, arterial clots, or stroke. SELECT showed a decrease, not an increase, in stroke events in the semaglutide arm.

Sustained tachycardia (resting heart rate consistently above 100 bpm) is not a typical Ozempic effect. A patient on Ozempic with new tachycardia needs a workup the same as anyone else with new tachycardia. Common causes include thyroid disease, anemia, dehydration, anxiety, and atrial fibrillation. The Ozempic dose is not the answer; the diagnostic workup is.

Direct effects on the heart muscle itself, in the sense of cardiomyopathy or impaired contractility, have not been demonstrated. Echocardiographic data from semaglutide trials show preserved left ventricular function. The chronotropic effect is on the sinoatrial node, not on contractility.

Wegovy versus Ozempic for cardiovascular effects

Wegovy and Ozempic are the same molecule, semaglutide. Wegovy goes up to 2.4 mg per week for weight loss; Ozempic tops out at 2.0 mg per week for type 2 diabetes. The heart rate effect and palpitation reports scale modestly with dose but the difference is small. The SELECT cardiovascular benefit was demonstrated with the Wegovy dose in patients without diabetes; the SUSTAIN-6 benefit was demonstrated with the Ozempic dose in patients with diabetes. Both products carry essentially the same cardiac side-effect profile ^[1]^[4].

Wegovy's FDA label was updated in 2024 to include the cardiovascular risk reduction indication based on SELECT, which is why insurance coverage for Wegovy expanded that year for patients with established cardiovascular disease.

Frequently asked questions

Does Ozempic cause heart palpitations?: Ozempic can cause palpitations in a minority of patients, mostly indirectly through dehydration, electrolyte loss, anxiety, or blood sugar swings. The direct effect on heart rate is a modest 2 to 4 bpm increase.
Does Ozempic raise heart rate?: Yes. The FDA label documents an average resting heart rate increase of 2 to 4 beats per minute in clinical trials. The effect is small, appears within weeks, and is stable over time.
Why does semaglutide increase heart rate?: GLP-1 receptors exist in cardiac tissue and in brainstem autonomic centers. Activation produces a small sympathetic chronotropic effect that the vagal counter-response does not fully cancel.
Does Wegovy cause heart palpitations?: At the same rate as Ozempic, roughly. Wegovy is the same molecule at a slightly higher maximum dose. The cardiac side-effect profile is essentially identical.
Can Ozempic cause a heart attack?: No. Clinical trials including SUSTAIN-6 and SELECT showed semaglutide reduces the risk of heart attack in at-risk patients. New chest pain still needs urgent evaluation, but the medication itself lowers cardiac event risk.
Is Ozempic good for your heart?: For patients with type 2 diabetes and cardiovascular disease, or obesity with cardiovascular disease, yes. SELECT showed a 20 percent reduction in major adverse cardiovascular events with semaglutide 2.4 mg weekly.
Can Ozempic cause blood clots?: No clinical trial signal supports an increased blood clot risk on semaglutide. SELECT showed fewer strokes in the semaglutide arm, not more.
Should I stop Ozempic if I get palpitations?: Not on your own. Most palpitations resolve with hydration, electrolyte replacement, and time. Call your prescriber. Stop and seek urgent care if palpitations come with chest pain, fainting, or shortness of breath.
How long do Ozempic heart palpitations last?: When they occur, most cases are brief, lasting seconds to minutes, and cluster in the first 8 to 12 weeks of treatment or after a dose increase. Persistent or worsening palpitations need a doctor visit.
Can I take Ozempic with a beta-blocker?: Yes. There is no direct interaction. The main caution is that beta-blockers mask hypoglycemia symptoms, which matters more if you also take insulin or a sulfonylurea.
What is the SELECT trial?: A 2023 NEJM trial of 17,604 adults with obesity and cardiovascular disease but no diabetes. Semaglutide 2.4 mg weekly reduced the composite of cardiovascular death, nonfatal heart attack, or nonfatal stroke by 20 percent versus placebo.

Bottom line

A small heart rate increase on Ozempic is expected and on the label. Palpitations are reported but uncommon, and when they happen they usually trace back to dehydration, electrolyte loss, anxiety, or hypoglycemia rather than a primary cardiac problem. The overall cardiovascular picture for semaglutide is positive in the populations studied. Track your pulse, hydrate, replace electrolytes, and call your doctor for chest pain, irregular rhythm, fainting, or severe shortness of breath. Those are the symptoms that change the calculus.